Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Torii Pharmaceutical and ASKA Pharmaceutical said on June 1 that they have sealed a promotion agreement for Riona Tablets (ferric citrate hydrate) for the treatment of iron deficiency anemia, an indication currently pending approval. Japan Tobacco, the parent company of…
To read the full story
Related Article
- JT Files Riona for Iron Deficiency Anemia in Japan
May 18, 2020
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





